Home
Home
  • Home
  • About Us About Us
    • Overview
    • Who we are
    • Why we provide advice
    • What are health technologies
    • Meetings
    • News
    • Who we work with
    • Contact Us
  • What We Do What We Do
    • Overview
    • Our Strategy
    • Work programme
    • Range of advice products
    • Quarterly Bulletin of advice
    • Early HTA Advice Service
  • Our Advice
  • Request Advice Request Advice
    • Overview
    • Form for requesting advice
  • Get Involved Get Involved
    • Overview
    • Contribute to advice
    • NHS boards
    • Patient and Public Involvement
    • Industry Involvement
    • Observe a council meeting
    • DOI Form

Advice Statement

  • Home
  • Our Advice
  • Musculoskeletal ultrasound for diagnosis to confirm or rule out a diagnosis of rheumatoid arthritis

Title

Output Type

Speciality

Published

Title

Musculoskeletal ultrasound for diagnosis to confirm or rule out a diagnosis of rheumatoid arthritis

Output Type

Advice Statement

Speciality

Musculoskeletal system

Published

22 September 2017

Recommendation for NHSScotland

There is evidence from a systematic review of a small number of studies to support the addition of Musculoskeletal Ultrasound to clinical assessment and laboratory testing to diagnose rheumatoid arthritis at an earlier stage of the disease. Use of ultrasound increased detection of joint inflammation and was more likely to correctly predict progression to inflammatory arthritis in patients with suspected rheumatoid arthritis.

No evidence was identified on the cost-effectiveness of MSUS in people with suspected rheumatoid arthritis.

NHSScotland is required to consider the Scottish Health Technologies Group (SHTG) advice.

What were we asked to look at?

In patients with suspected rheumatoid arthritis, does the addition of musculoskeletal ultrasound increase the ability of rheumatologists to confirm or rule out a diagnosis of rheumatoid arthritis at an earlier stage compared to conventional diagnostic assessment alone?

Why is this important?

With an increasing older population in Scotland the prevalence of rheumatoid arthritis is expected to increase. Early initiation of treatment with disease modifying anti-rheumatic drugs (DMARDs) - in the first weeks or months after symptoms develop - can prevent joint damage, improve longterm physical function and increase the likelihood of achieving clinical remission. Conventionally, diagnostic assessment for people with suspected rheumatoid arthritis has involved a clinical examination, laboratory tests and x-ray of the affected joints. Musculoskeletal ultrasound (MSUS) of the affected joints has been proposed as an additional aid to early diagnosis of people with suspected rheumatoid arthritis.

Referred by

The Scottish Society for Rheumatology.

Download icon
Download Advice
pdf (432 KB)
Download icon
Download Plain Language Summary
pdf (329 KB)
Download icon
Download Evidence note
pdf (723 KB)

Connect with Us

Please let us know if you'd like to receive regular updates on our work.


Last Updated: 31 January 2022

Scottish Health Technologies Group

© 2021, All rights reserved

  • Accessibility
  • Respecting your privacy
  • Cookies
  • Healthcare Improvement Scotland Website
  • Find us on Twitter
  • Freedom of Information

Tell us what you think


We'd love to hear your views

Was our advice useful?  Did you find what you were looking for on our website?